These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12361196)

  • 1. Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions.
    Haznedaroglu IC; Goker H; Turgut M; Buyukasik Y; Benekli M
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):193-212. PubMed ID: 12361196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.
    Kuter DJ; Begley CG
    Blood; 2002 Nov; 100(10):3457-69. PubMed ID: 12411315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical findings with the first generation of thrombopoietic agents.
    Vadhan-Raj S
    Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.
    Vadhan-Raj S
    Semin Hematol; 2000 Apr; 37(2 Suppl 4):28-34. PubMed ID: 10831286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Romiplostim: a second-generation thrombopoietin agonist.
    Cohn CS; Bussel JB
    Drugs Today (Barc); 2009 Mar; 45(3):175-88. PubMed ID: 19436840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
    Hofmann WK; Ottmann OG; Hoelzer D
    Leukemia; 1999 Apr; 13 Suppl 1():S14-8. PubMed ID: 10232362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions with platelet growth factors.
    Kuter DJ
    Semin Hematol; 2000 Apr; 37(2 Suppl 4):41-9. PubMed ID: 10831288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic potential of thrombopoietin].
    Geissler K
    Wien Klin Wochenschr; 2000 Oct; 112(19):829-34. PubMed ID: 11098533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New thrombopoietic growth factors.
    Kuter DJ
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S347-56. PubMed ID: 19778863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietins and thrombopoiesis: a clinical perspective.
    Kuter DJ
    Vox Sang; 1998; 74 Suppl 2():75-85. PubMed ID: 9704427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of thrombopoietin on clinical practice.
    Basser R
    Curr Pharm Des; 2002; 8(5):369-77. PubMed ID: 12069375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of thrombopoietin (c-Mpl Ligand)].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the potential for thrombopoietic agents in acute leukemia?
    Kuter DJ
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):553-8. PubMed ID: 22127320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.
    Vadhan-Raj S
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S26-32. PubMed ID: 19245931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic aspects of thrombopoietins and the development of therapeutic agents.
    Solberg LA
    Curr Hematol Rep; 2005 Nov; 4(6):423-8. PubMed ID: 16232377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietic agents.
    Stasi R; Bosworth J; Rhodes E; Shannon MS; Willis F; Gordon-Smith EC
    Blood Rev; 2010; 24(4-5):179-90. PubMed ID: 20493600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment options in patients with thrombocytopenia.
    Demetri GD
    Semin Hematol; 2000 Apr; 37(2 Suppl 4):11-8. PubMed ID: 10831284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.
    Schuster MW; Beveridge R; Frei-Lahr D; Abboud CN; Cruickshank S; Macri M; Menchaca D; Holden J; Waller EK
    Exp Hematol; 2002 Sep; 30(9):1044-50. PubMed ID: 12225796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.